| dc.contributor.author | Yaylim, I | |
| dc.contributor.author | ISBIR, TURGAY | |
| dc.date.accessioned | 2021-03-03T14:27:19Z | |
| dc.date.available | 2021-03-03T14:27:19Z | |
| dc.identifier.citation | Yaylim I., ISBIR T., "Enhanced casein kinase II (CK II) activity in human lung tumours", ANTICANCER RESEARCH, cilt.22, ss.215-218, 2002 | |
| dc.identifier.issn | 0250-7005 | |
| dc.identifier.other | vv_1032021 | |
| dc.identifier.other | av_398fae7a-be87-427a-a239-76f39c879402 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.12627/42728 | |
| dc.description.abstract | Background: Casein kinase 11 (CK II) is expressed at a higher level in lung tumours when compared to the corresponding non-neoplastic lung tissue. Materials and Methods: The aim of the present study was to evaluate the activity of CK II both in neoplastic and non-neoplastic human lung tissue by using a synthetic peptide with Arg-Arg-Arg-Asp-Asp-Asp-Ser-Asp-Asp-Asp (RRRDDDSDDD) sequence. One unit of CK If activity is defined as the amount catalysing the transfer of I pmol P-32 into the substrate within I minute at 37degreesC. Results: The activities measured for the neoplastic and non-neoplastic tissues were 1250-1500 U/mg protein and 100-500 U/mg protein, respectively. According to these results, the maximum activity observed in the lung carcinomas was 2 to 3-fold higher than the lung tumour specimens when compared to the non-neoplastic lung tissue. The activity range of CK II was between 500-1500 U mg protein. Conclusion: Our results suggest that CK 11 plays an important role in cellular proliferation and the mechanism of its activation. | |
| dc.language.iso | eng | |
| dc.subject | İç Hastalıkları | |
| dc.subject | Onkoloji | |
| dc.subject | Sağlık Bilimleri | |
| dc.subject | Dahili Tıp Bilimleri | |
| dc.subject | Tıp | |
| dc.subject | Klinik Tıp (MED) | |
| dc.subject | Klinik Tıp | |
| dc.subject | ONKOLOJİ | |
| dc.title | Enhanced casein kinase II (CK II) activity in human lung tumours | |
| dc.type | Makale | |
| dc.relation.journal | ANTICANCER RESEARCH | |
| dc.contributor.department | İstanbul Üniversitesi , Aziz Sancar Deneysel Tıp Araştırma Enstitüsü , Moleküler Tıp Ana Bilim Dalı | |
| dc.identifier.volume | 22 | |
| dc.identifier.startpage | 215 | |
| dc.identifier.endpage | 218 | |
| dc.contributor.firstauthorID | 64248 | |